News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Regulatory
CFDA To Start 60-Day Approvals For INDs Of Oncology Drugs 8/28/2015
WuXi PharmaTech (WX)'s STA Subsidiary Receives First Approval From Japanese Regulatory Authorities 8/27/2015
Arcadia Biosciences (RKDA) Release: Verdeca’s HB4 Stress Tolerance Trait Completes FDA Early Food Safety Evaluation 8/26/2015
EDAP TMS S.A. (EDAP) Provides Formal Response To FDA Addressing All Concerns Raised In July 2015 Ablatherm HIFU Letter 8/25/2015
InformedDNA Achieves NCQA Utilization Management Certification 8/25/2015
Sarepta (SRPT) Receives Rare Pediatric Disease Designation From FDA For Eteplirsen For The Potential Treatment Of Duchenne Muscular Dystrophy 8/21/2015
CombiMatrix (CBMX)'s Combisnp Array For Prenatal Diagnosis Test Granted Approval From New York City Department of Health and Mental Hygiene 8/18/2015
Radiant Sage Achieves ISO 9001: 2008 Quality Management System Certification 8/18/2015
PAREXEL International (PRXL) Receives CEO Cancer Gold Standard Accreditation 8/13/2015
SynteractHCR Requalifies As Certified Member Of BVMA, The Federal Association Of CROs In Germany 8/12/2015
Symbiosis Pharmaceutical Services Release: Successful Sterile Inspection For Scottish CMO 8/10/2015
COLA Accreditation Renewed For Moleculera Labs Testing Services For Childhood Autoimmune Conditions Affecting Brain And Behavior 8/6/2015
Agendia BV Release: NCCN Breast Cancer Guidelines Acknowledge MammaPrint’s Ability to Predict Prognosis 7/28/2015
IndiPharm Awarded Bionexus Status By Malaysian Biotechnology Corporation 7/28/2015
Cellular Biomedicine Group (CBMG) Announces Successful New Certifications For Proprietary Cell And Tissue Preservation Media Kits 7/27/2015
HTG Molecular Diagnostics Achieves ISO 13485:2003 Recertification 7/24/2015
Sigma-Aldrich Corporation (SIAL) Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials 7/23/2015
European Medicines Agency Release: Stimulating The Development Of Medicines For Children 7/23/2015
FDA QIDP Designation for Motif’s Lead Antibiotic Candidate Iclaprim For ABSSSI 7/23/2015
Aratana Therapeutics (PETX) Provides Update On Monoclonal Antibody Products 7/22/2015
Konica Minolta Medical Imaging U.S.A, Inc. (KPI1.BE) AeroDR Achieves Compliance With FIPS 140-2 Security Standard For DoD AND VA Facilities 7/21/2015
PPD, Inc. (PPDI) Achieves CEO Cancer Gold Standard Reaccreditation 7/20/2015
NanoString (NSTG) Release: NCCN Clinical Practice Guidelines For Breast Cancer Acknowledge Prosigna/PAM50 As Clinically Validated For Prediction Of Prognosis 7/17/2015
Amerita Receives Full URAC Specialty Pharmacy Accreditation 7/17/2015
NMS Labs Earns Prestigious International Accreditation From The American Society Of Crime Laboratory Directors/Laboratory Accreditation Board (ASCLD/LAB) 7/16/2015
Roka Bioscience, Inc. (ROKA) Receives AOAC Certification For The Atlas Listeria Environmental Detection Assay 7/15/2015
Vericel (ASTM) Announces Plan To Submit HDE Supplement To The FDA To Revise The Labeled Indications For Use And Add Pediatric Labeling For Epicel 7/14/2015
ASPiRA Labs Receives New York State Permit 7/13/2015
Neogen Corporation (NEOG)'s ANSR For Listeria monocytogenes Receives AOAC Approval 7/10/2015
Indian CRO Quality Questioned, As Quest Life Sciences Warned by WHO for HIV Trial Fraud 7/9/2015
Arrowhead Research Corporation (ARWR) Receives Regulatory Clearance For ARC-AAT Phase 1 In The United Kingdom And New Zealand 7/8/2015
Prima Biomed (PRR.AX) Receives Positive Scientific Advice From European Medicines Agency For Its Lead Product, IMP321 7/7/2015
Esperion Therapeutics (ESPR) Announces Removal Of 240 mg Partial Clinical Hold For ETC-1002 7/7/2015
Mauna Kea Technologies Receives Regulatory Approval For The AQ-Flex 19 Miniprobe In Japan 7/6/2015
BGI Receives Accreditation From The College of American Pathologists 7/6/2015
Innocoll, Inc. (INNL) Announces Qualified Infectious Disease Product (QIDP) Designation For Cogenzia For The Adjunctive Treatment Of Moderate And Severe Diabetic Foot Infection 6/30/2015
ImmunID Receives Accreditation From College of American Pathologists 6/30/2015
Elevance Aria WTP 40 Certified As HX-1 Food-Grade 6/30/2015
Sirona Biochem Appoints Casper Bych To Its Board of Directors 6/29/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Polydrug Laboratories Due To Data Integrity Concerns 6/25/2015
Beximco Pharmaceuticals Receives U.S. FDA Approval 6/24/2015
Protagen AG Achieves Significant Milestone With ISO 13485 Certification 6/24/2015
TOMI Receives EPA Registration For Its Patented BIT Technology 6/24/2015
Thermo Fisher Scientific (TMO) Release: OIE Approves Registration Of BOVIGAM TB Kit In Diagnostics Manual, Boosting Global Effort To Manage Bovine Tuberculosis 6/24/2015
Verdezyne, Inc. Earns USDA Certified Biobased Product Certification And Label 6/24/2015
Arcadia Biosciences (RKDA)’ Gamma-Linolenic Acid Safflower Meal Receives Approval From FDA For Use In Animal Feed 6/23/2015
AOP Orphan Pharmaceuticals AG Strengthens Core CNS Specialty Business With High Promise In Movement Disorder Treatments 6/19/2015
Cleveland Biolabs Inc. (CBLI) Submits Pre-EUA Dossier For Entolimod To FDA 6/16/2015
Intellirod Spine Raises Capital And Obtains ISO Certification 6/16/2015
Ajinomoto Althea Inc. Receives European GMP Certification For Commercial Aseptic Filling And Testing 6/16/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Zhejiang Hisun Pharma Due To Data Integrity Concerns 6/16/2015
Intertek Gains Official Accreditation With Philippine Food And Drug Administration 6/16/2015
Aerie (AERI) Receives Positive Feedback From FDA 6/16/2015
PDCLine Pharma Receives Advanced-Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its New Class Of Therapeutic Cancer Vaccines (PDCvac) 6/15/2015
Leica Microsystems' Vienna Plant Certified For DIN EN ISO 14001 6/15/2015
FDA Agrees With OncoGenex Pharmaceuticals Inc. (OGXI)' Phase 3 AFFINITY Protocol Amendment 6/10/2015
BioPharma Services Inc. Scores Another Perfect U.S. FDA Audit 6/10/2015
Lyophilization Services Of New England Completes Successful FDA Pre-Approval Inspection For Sterile Drug Product 6/9/2015
Palatin Technologies (PTN) Supports FDA Advisory Committee's Recommendation To Approve The First-Ever Treatment For Hypoactive Sexual Desire Disorder 6/5/2015
MediciNova, Inc. Announces FDA Granted Orphan Drug Designation To MN-166 (Ibudilast) For Krabbe Disease 6/3/2015
AmpliPhi Biosciences Corporation (APHB)’s Bacteriophage Manufacturing Facility Receives cGMP Certification 6/3/2015
The FDA Accepts To Review Theraclion's Submission For Approval Of An Echopulse Pivotal Trial In The U.S. 6/3/2015
China's CFDA Raises Fees For Drug Review 5/28/2015
Colorcon, Inc.’s UK Site Adds EXCiPACT Certification To Support Pharmaceutical Customers To Reduce Growing Regulatory Requirements 5/28/2015
KCR Accomplishes ISO 9001:2008 Certification For All Company Services 5/26/2015
PTC Therapeutics (PTCT) Release: German Federal Joint Committee Issues Positive Medical Benefit Rating For Translarna In Patients With Nonsense Mutation Duchenne Muscular Dystrophy 5/22/2015
Protein Sciences Corporation New York Facility Receives FDA Licensure To Manufacture Flublok 5/14/2015
Sinovac Biotech Ltd. (SVA) Receives Site Inspection Notification For EV71 Vaccine Production Facilities 5/14/2015
Accutest Recently Completed Its 22nd Successful FDA Inspection 5/13/2015
MicroBiome Therapeutics LLC Receives Positive Response From FDA For Use Of Expedited Regulatory Pathway For Diabetes Drug Nm505 5/12/2015
FDA Performs GMP And Pre-Approval Inspections Of IMPAX Labs (IPXL)'s Hayward Facility 5/12/2015
WIRB-Copernicus Group Release: New England IRB Awarded AAHRPP Reaccreditation 5/11/2015
European Medicines Agency And Evidera Release Draft Opinion On Two Patient-Reported Outcome (PRO) Measures For Evaluating New Treatments For COPD 5/11/2015
FutureCeuticals' elevATP Is Non-GMO Project Certified And Verified 5/11/2015
T-Bird Pharma Announces Health Canada License Renewal Including Full Authorization To Sell 5/7/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Gastric Cancer 5/6/2015
NSF Approves Flex Pharma (FLKS)’s Proprietary Formulation Under NSF’s Certified For Sport Program 5/4/2015
IDEAL CURES Becomes The First Indian Excipients Company To Receive Excipact Certification 5/4/2015
Integrated Service Solutions, Inc. Successfully Completes ISO Surveillance Audit 5/4/2015
Human Longevity Inc. Receives CLIA Certification 4/29/2015
CannRx Technology Partner Receives ISO 17025 Certification For Its Laboratory 4/28/2015
FDA Grants Orphan Drug Designation For DCR-PH1, Dicerna (DRNA)’s Investigational Therapy For The Treatment Of Primary Hyperoxaluria Type 1 (PH1) 4/24/2015
Emergent BioSolutions (EBS) Completes Investigation And Resumes Biothrax Manufacturing Activities; Re-Affirms Previous Full-Year 2015 Financial Outlook 4/23/2015
Lucideon (Formerly Known As CERAM) Receives ISO 17025 Accreditation For Wear Testing 4/23/2015
Agilent Technologies Inc. (A) Announces Resolution To U.S. FDA Warning Letter For Dako Denmark 4/22/2015
Integrated DNA Technologies’s San Diego, California, Manufacturing Facility Receives ISO 14001 Certification 4/22/2015
Pernix (PTX) Obtains Six Months U.S. Pediatric Exclusivity For Treximet 4/20/2015
Centene Corporation Release: Nurtur Receives Full URAC Accreditation 4/17/2015
TWi Pharmaceuticals, Inc. USA Announces The Receipt Of State Sales Licenses From All 50 States In The U.S. 4/17/2015
Hospira Slapped Again By the FDA for Plant Problems 4/16/2015
Juniper Pharma Services Obtains Specials Licence 4/16/2015
T-Bird Pharma Inc. Announces Health Canada Submission For Second Production Facility 4/10/2015
FL-Based Biotech, AmnioLife, Completes Product Sterilization Validation 4/8/2015
Shire (SHPGY) Announces Clear Regulatory Path Forward For SHP465, An Investigational Treatment For Adults With ADHD 4/7/2015
Cellular Biomedicine Group (CBMG)'s Shanghai Facility Passes Fourth Consecutive CFDA Inspection 4/6/2015
Subsidiary Of Immunoclin Corporation (IMCL) Receives Controlled Drug License In The United Kingdom 4/2/2015
Sysmex America, Inc. Receives U.S. Department Of Defense Accreditation For WAM Middleware Solution 4/1/2015
Innate Pharma (IPH.PA ) : DSMB Recommends Continuation Of Effikir Trial With Two Arms 3/30/2015
Onyx Scientific Limited Release: CRO To Expand GMP Capability 3/30/2015
European Medicines Agency Release: Gardasil 9 Offers Wider Protection Against Cancers Caused By Human Papillomavirus (HPV) 3/27/2015
TransUnion Approved By SAFE-BioPharma, LLC Trust Framework 3/25/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Status From The European Medicines Agency For Ovarian Cancer 3/25/2015
Faster FDA Means More Cancer Breakthroughs 3/24/2015
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion On Application For Orphan Designation By The European Medicines Agency Agency For Ampligen To Treat Patients With Ebola Virus Disease (EVD) 3/24/2015
Kemwell Announces Successful FDA Inspection 3/24/2015
InMed Receives Exemption Status From Health Canada 3/23/2015
Pfenex (PFNX) Announces Early HSR Clearance For Collaboration With Hospira 3/23/2015
THERAVECTYS Granted Authorization By The French National Agency For Medicines To Produce Lentiviral Vectors For Clinical Use And CAR-T Cell Therapies Under GMP Standards 3/23/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
Mesoblast Limited (MSB.AX) Selected For Fast Track Access To Potential Investment Incentives In Japan 3/19/2015
Opko Health, Inc. (OPK) Receives Accreditation From College of American Pathologists 3/18/2015
NYU Langone Medical Center Release: Quality Measures Approved For Childhood Sleep Apnea 3/16/2015
WIRB-Copernicus Group Release: Western Institutional Review Board Receives ISO 9001:2008 Certification 3/16/2015
FDA Rates Kitabis Pak As Therapeutic Equivalent Of TOBI 3/16/2015
MedSource National Completes SOC 2 Type II Audit With No Exceptions 3/10/2015
FDA Wants AcelRx (ACRX) to Run Another Trial on Zalviso Drug-Device Combo 3/10/2015
EXCLUSIVE: Experimental Cancer Drug From Oncoceutics Could Be Fast-Tracked, Says Exec 3/6/2015
Axsome Announces FDA Fast Track Designation For AXS-02 For The Treatment Of Pain Associated With Complex Regional Pain Syndrome 3/5/2015
Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Eli Lilly (LLY) For Development As A Personalized Medicine 3/3/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
TherapeuticsMD, Inc.  (TXMD) Has "Multiple Catalysts" in 2015/16 As Products Develop, Says Cowen and Company 2/26/2015
Federal Trade Commission Cracks Down on Marketers of "Melanoma Detection" Apps 2/24/2015
Medicago, Inc. Awarded A Contract By The U.S. Department Of Health And Human Services To Explore Alternate Production Methods For Ebola Antibodies 2/24/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
Vexim Announces Successful GMP Inspection by Brazil's National Health Surveillance Agency 2/19/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Pancreatic Cancer 2/17/2015
Siegfried Announces Comprehensive Solution For The Hameln Facility’s Regulatory Issues 2/16/2015
Emergent BioSolutions (EBS) Announces Primary Endpoints Met In Pivotal Study Supporting Licensure Of Building 55 2/13/2015
Contract Research Organization WCCT Global Certifies Laboratory Staff In Peripheral Blood Mononuclear Cell (PBMC) Isolation 2/12/2015
NanoSmart Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation For ANA-Conjugated Liposomal Doxorubicin For The Treatment Of Ewing's Sarcomaf 2/11/2015
T-Bird Pharma Inc. Announces License Renewal From Health Canada 2/10/2015
Symphony Clinical Research Gains Women’s Business Enterprise Certification 2/10/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For High Grade Gliomas In Pediatric Patients 2/9/2015
Solentim Awarded Quality Management System (QMS) Certification - ISO 9001:2008 2/9/2015
CASI Pharmaceuticals  (CASI) Announces Receipt Of Final Minutes From FDA Meeting Regarding Clinical And Regulatory Path Of ENMD-2076 For The Treatment Of Patients With Fibrolamellar Carcinoma (FLC) 2/9/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
FDA Snatches Back Breakthrough Status for Merck & Co. (MRK) Hepatitis C Drugs 2/5/2015
Aesica Secures Continuing FDA Approval Of Its Bulk Manufacture And Packaging Sites In Germany 2/2/2015
Rock Creek Pharmaceuticals Receives Clinical Trial Application Approval 1/30/2015
Opko Health, Inc. (OPK) And Pfizer (PFE) Receive Regulatory Clearance For Global Agreement 1/29/2015
Averica Announces Approved DEA Registration To Research Schedule I Controlled Substances 1/28/2015
Octapharma USA, Inc. Announces FDA Approval For 2nd Octagam® 10% Manufacturing Site, Expanding Product Availability 1/26/2015
Tianyin Pharmaceutical Co, Inc.'s JCM Updates On Import Registration For International Clients 1/26/2015
Neuland Labs Reports Another Successful FDA Audit And Wins 2015 CMO Leadership Award 1/26/2015
Frequentz Simplifies GS1 Compliance For Pharmaceutical Supply Chain To Meet FDA Drug Supply Chain Security Act Extended Deadline 1/22/2015
Prosolia, Inc. Expands Capacity And Achieves ISO 9001:2008 Quality Management System Certification 1/22/2015
NeoStem, Inc. Receives Drug Manufacture License For Irvine Facility 1/20/2015
Tianyin Pharmaceutical Co, Inc. QLF Received GMP Certification 1/20/2015
Mylan Inc. (MYL) Release: U.S. Supreme Court Partially Modifies Standard Of Review Of Patent Claim Construction And Remands Review Of Teva's '808 Patent On Copaxone® To Federal Circuit Court Of Appeals 1/20/2015
Ariad Pharmaceuticals, Inc. (ARIA) Announces Final Decision From European Commission Endorsing Iclusig’s Approved Indications Throughout Europe 1/20/2015
United States Department Of Agriculture (USDA) Deregulates Monsanto Company (MON)’s Next-Generation Weed Control Trait Technology 1/16/2015
Veloxis Pharmaceuticals A/S (VELO) Confirms Receipt Of U.S. FDA Administration Decision 1/13/2015
Axxess Pharma, Inc. Receives Approval By Major Canadian Distributor To Sell TapouT Products To Over 2,000 Independent Pharmacies 1/13/2015
Achaogen (AKAO) Announces Plazomicin Granted QIDP Designation By FDA 1/8/2015
Epic Sciences Receives CLIA Certification For Its Cancer Diagnostics Laboratory 1/8/2015
TPI QLF To Receive GMP Certification 1/8/2015
Tauriga Sciences Inc. (TAUG) Confirms That Canadian Trading Halt (Cease Trade) Has Been Lifted By Autorite Des Marches Financiers (Quebec Based Regulatory Authority) 1/8/2015
Aratana Therapeutics (PETX) Granted Full License For AT-004 By United States Department Of Agriculture (USDA) 1/6/2015
Buchang Pharma Visits Tianyin Pharmaceutical Co, Inc. Qionglai Facility 1/6/2015
Tianyin Pharmaceutical Co, Inc. QLF Achieved Public Notice Status Of GMP Certification 12/24/2014
Acquisition Of Sigma-Aldrich Corporation (SIAL) By Merck KGaA (MKGAF.PK), Darmstadt, Germany, Receives U.S. Antitrust Clearance 12/23/2014
China Biologic Products Receives GMP Certification For New Coagulation Factor Facility 12/23/2014
Successful FDA Inspection At Hovione 12/18/2014
EXCLUSIVE: Sanofi Pasteur (SASY.PA) US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax 12/18/2014
Marrone Bio Innovations, Inc' REGALIA® MAXX Biofungicide Receives Registration In Brazil 12/17/2014
ImmunID Receives Authorization to Start Its PREDICT-ID Clinical Trial in Metastatic Melanoma Patients Treated With an Immune Checkpoint Inhibitor 12/10/2014
Vigilant Biosciences, Inc. Marks Significant Milestone With ISO 13485:2003 Certification 12/10/2014
Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam 12/8/2014
NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Earns AABB Re-Accreditation For Its Allendale, NJ Manufacturing Facility 12/8/2014
Metamark Laboratory Received Accreditation From College of American Pathologists 12/8/2014
Sanofi (SAN.PA) Chairman Says French Tax Burden Is Hindering Hunt For New CEO 12/8/2014
IntelGenx Corp. Grants Extension Of Marketing Exclusivity In The U.S. To Edgemont Pharmaceuticals, LLC. Of Forfivo XL(R) 12/5/2014
Fifteen Indians Blinded After Surgery With Suspected Infected Tools 12/5/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
Cellectar Biosciences  (NVLT) Granted Orphan Designation For I-131-CLR1404 For The Treatment Of Multiple Myeloma 12/5/2014
GVK Biosciences Review: Some Member States Suspend Marketing Authorisations For Concerned Medicines 12/5/2014
ChemoCentryx, Inc. (CCXI) Granted EU Orphan Drug Designation For CCX168, An Orally Administered Complement C5a Receptor Inhibitor, For The Treatment Of Microscopic Polyangiitis And Granulomatosis With Polyangiitis, Two Forms Of ANCA-Associated Vasculitis 12/4/2014
CytRx Corporation (CYTR) Receives Written FDA Communication Regarding Partial Clinical Hold For Aldoxorubicin Clinical Trials 12/4/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
Venaxis, Inc. (APPY) Files Response To FDA's Request For Additional Information 12/4/2014
CorMedix (CRMD) Files Request With FDA For QIDP Designation For Neutrolin 12/4/2014
Maharashtra FDA Executes "Surprise Inspection Spree" On Hundreds Of Pharma Units 12/3/2014
Germany Bars Antibiotic Cephalosporin From Ranbaxy Laboratories (RANBAXY.BO)'s Madhya Pradesh Plant 12/3/2014
Rhinomed Mute Granted US FDA Registration 12/3/2014
Novartis AG (NVS)' Heart Failure Medicine LCZ696 Granted Accelerated Assessment By CHMP In Europe 12/2/2014
Relmada Therapeutics Receives Health Canada Clearance To Commence First Clinical Study Of D-Methadone 12/2/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For Pancreatic And Ovarian Cancers 12/2/2014
Inventiva Receives Another Positive Opinion On Orphan Drug Designation In The European Union For IVA337 – For Idiopathic Pulmonary Fibrosis 12/2/2014
Ignyta (RXDX) Announces CLIA Certification Achieved By Its Diagnostic Laboratory 12/2/2014
SureClinical Wins FDA Part 11 And EC Annex 11 Compliance Validation 12/1/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback From European Medicines Agency On Advancing ICT-107 To Phase 3 Program 12/1/2014
FDA Priority Review Voucher Scheme Under Fire 11/26/2014
Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation From European Medicines Agency 11/24/2014
Beximco Pharmaceuticals Becomes First Bangladeshi Company To Receive GMP Approval From Health Canada 11/24/2014
FDA Grants QIDP Designation To Bayer AG (BAYZF)'s Amikacin Inhale And Ciprofloxacin Dry Powder For Inhalation 11/24/2014
Yabao Pharmaceuticals In-licenses China Rights To Parkinson's Drug Technology 11/21/2014
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG (NVS)'s Xolair To Treat Chronic Hives 11/20/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Terumo BCT And Banco de Sangre de Servicios Mutuos Unite In A Treatment Use Program Developed To Help Improve Blood Supply Safety Using An Investigational Device 11/19/2014
FDA Puts Partial Hold On CytRx Corporation (CYTR)'s Aldoxorubicin Clinical Trials 11/19/2014